The “news”: As usual, digital health companies swarmed the annual CES show in Las Vegas with new patient monitoring products and technologies. Some will prove too pricey for consumers, while others offer single-point solutions that won’t appeal to providers.
A sampling of new products showcased the full gamut of digital health:
Also at CES: Teladoc introduced a refreshed app that gives users one login and one platform to access its primary care, mental health, and chronic care offerings in English and Spanish, per Modern Healthcare.
Our take: 2023 looks to be a pivotal year for digital health companies, as macroeconomic conditions continue to push investors’ demand for profitability over growth. At the same time, customers (in the form of patients, providers, employers, and insurers) are looking for technologies that prove their clinical worth and deliver seamless care journeys.
For patients, that means a suite of interoperable monitoring devices that measure biometric or other data and transmit results to their caregiver(s). Single-purpose devices for sleep, weight, heart rate, medication compliance, and other care factors become burdensome and eventually not used.
For providers, proven clinical data and outcomes are required to get consideration, and integration with existing electronic medical record systems is becoming a necessity. Products and technologies that add to clinicians’ workflow or require more staff to monitor patients’ data won’t find many buyers.
Employers and insurers are inundated with digital companies trying to get their products in front of patients. They’re looking for end-to-end solutions that their members will actually use to improve their health outcomes (which = lower medical costs).
This article originally appeared in Insider Intelligence's Digital Health Briefing—a daily recap of top stories reshaping the healthcare industry. Subscribe to have more hard-hitting takeaways delivered to your inbox daily.
One Liberty Plaza9th FloorNew York, NY 100061-800-405-0844